Answers are grounded in this paper and cite their sources.
Background Population ageing has led to a growing prevalence of multimorbidity and polypharmacy, especially among institutionalized older adults. Polypharmacy, commonly defined as the concurrent use of five or more medications, poses significant risks, including adverse drug reactions, poor adherence, cognitive decline, and reduced quality of life. Despite global evidence linking polypharmacy with diminished health-related quality of life (HRQOL) and heightened psychological distress, Sri Lanka lacks research examining this relationship within elderly care homes, a population uniquely vulnerable due to chronic illness, social isolation and dependence on caregivers. This study aims to assess health related quality of life and psychological distress among elderly residents with polypharmacy in selected elderly care homes in the Colombo District, Sri Lanka, exploring the relationships between polypharmacy and these outcomes, and associations of these outcomes with key sociodemographic factors. Methods A descriptive cross-sectional study was conducted among elderly residents (≥ 60 years) experiencing polypharmacy across 10 registered elderly care homes. A stratified random sample of 201 participants proportionately from each care home was selected. Data was collected through interviewer-administered questionnaires using validated tools: WHOQOL-BREF for health-related quality of life and Depression Anxiety Stress Scale–21 (DASS-21) for psychological distress. Medication data were extracted via a structured checklist. Non-parametric tests, including Chi-square and Spearman correlation, and multiple linear regression were used for analysis. Results Most participants (96.5%) reported moderate HRQOL, while 82.1% demonstrated at least mild depressive symptoms, and 64.7% reported anxiety symptoms. Polypharmacy showed a significant negative association with HRQOL (χ² = 7.24, p = 0.027; ρ = − 0.449, p < 0.001) and significantly predicted poor HRQOL (β = − 0.41, p < 0.001). A strong positive association was observed between polypharmacy and psychological distress (χ² = 85.03, p < 0.001; ρ = 0.785, p < 0.001), with regression showing polypharmacy predicting higher distress levels (β = 0.78, p < 0.001). Conclusion High polypharmacy is significantly associated with reduced HRQOL and heightened psychological distress among institutionalized elderly in the Colombo district, Sri Lanka. These findings underscore the need for routine medication reviews, deprescribing strategies and enhanced psychological support that are essential to improve the well-being in this medically and socially vulnerable population.
No takes yet. Share an insight, caveat, or question.
Wickramanayake et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: